Innovating Works

MeMed Diagnostics

Desconocido
DECODE: reDucing the health and Economic COst of Diagnostic uncErtainty establishing potential applications... MEMED DIAGNOSTICS LTD tramitó un H2020: H2020-EIC-SMEInst-2018-2020 Problem: Clinicians routinely face diagnostic uncertainty because acute infections are often clinically indistinguishable and today’s diagno...
2019-12-20 - 2021-12-31 | Financiado
AutoPilot-Dx: Fast tracking market adoption of a novel immune based diagnostic for improving antibiotic stewardshi... MEMED DIAGNOSTICS LTD tramitó un H2020: H2020-FTIPilot-2015-1 MeMed has completed development of ImmunoXpert™, an in vitro diagnostic test that leverages the body’s immune system to accurately different...
2016-08-08 - 2019-08-31 | Financiado
Respiratory-ImmunoDx: Clinical validation of host biomarker signature for distinguishing bacterial versus viral lower resp... MEMED DIAGNOSTICS LTD tramitó un H2020: H2020-SMEInst-2014-2015 Lower respiratory tract infection (LRTI) is the 3rd leading cause of death worldwide. In the EU 30 million incidents occur annually, with as...
2015-11-27 - 2018-11-30 | Financiado
TAILORED-TREATMENT: DEVELOPMENT OF TAILORED ANTIMICROBIAL TREATMENT REGIMENS AND NOVEL HOST PATHOGEN INSIGHTS FOR RESP... MEMED DIAGNOSTICS LTD participó en un FP7: Though of tremendous benefit, the overuse of antibiotics has lead to the emergence of antibiotic resistance and may cause adverse events tha...
Financiado
* Datos extraídos de la documentos o webs disponibles en diferentes organismos públicos.